Global Wound Irrigation Solutions Market to accrue $ 2153.51 Mn by 2027

December 11, 2019


According to the new research report available at MarketStudyReport.com under the title ‘Wound Irrigation Solutions Market to 2027 - Global Analysis and Forecasts By Product (Wetting Agents, Antiseptics and Topical Antibiotics); End User (Hospitals & Clinics, Ambulatory Surgical Centers and Homecare Facilities), and Geography’, the worldwide wound irrigation solutions market is anticipated to amass USD 2153.51 million by the year 2025.
 

Across the globe, roads are shared by buses, motorcycles, taxis, pedestrians, cars, trucks, mopeds, and other modes of travel, owing to which number of road accidents is increasing on daily basis. As per CDC (Centers for Disease Control and Prevention) data published in 2016, injuries due to road accidents lead to a significant economic burden on the middle and lower-income countries. Hence, surging cases of road trauma is the main driver for the growth of wound irrigation solutions market.
 

When performed correctly, wound irrigation can improve wound healing by decreasing infection and its associated morbidities. It is an integral part of wound management and is the only biggest intervention in wound care that can lower the risk of infection. However, absence of well-defined reimbursement policies might restrain wound irrigation solutions industry.
 

As per the report, wound irrigation solutions market was worth USD 1580.14 million in the year 2018 and is anticipated to expand with a CAGR of 3.5% through the year 2027, thereby reaching USD 2153.51 million.
 

Wound irrigation solutions market is analyzed on the basis of product, end-user, and geographical landscape. Based on the product, the market is segmented as topical antibiotics, wetting agents, and antiseptics. While considering the end-user spectrum, the market is fragmented as homecare facilities, ambulatory surgical centers, and hospitals & clinics.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2202072/
 

Speaking of the geographical landscape, the global wound irrigation solutions industry is bifurcated into regions namely Europe, South America, Asia Pacific, North America, and Middle East & Africa.
 

The prominent companies operating in wound irrigation solutions market include B. Braun Melsungen AG, C.R. Bard, Inc., Convatec Group Plc., Smith & Nephew, Schulke & Mayr, Medline Industries, Inc., Novabay Pharmaceuticals, Inc., Reckitt Benckiser Group Plc., Cardinal Health, Inc., and Coloplast Group.


Frequently Asked Questions (FAQ) :

Across the globe, roads are shared by buses, motorcycles, taxis, pedestrians, cars, trucks, mopeds, and other modes of travel, owing to which number of road accidents is increasing on daily basis. As per CDC (Centers for Disease Control and Prevention) data published in 2016, injuries due to road accidents lead to a significant economic burden on the middle and lower-income countries. Hence, surging cases of road trauma is the main driver for the growth of wound irrigation solutions market.
Wound irrigation solutions market is analyzed on the basis of product, end-user, and geographical landscape. Based on the product, the market is segmented as topical antibiotics, wetting agents, and antiseptics. While considering the end-user spectrum, the market is fragmented as homecare facilities, ambulatory surgical centers, and hospitals & clinics. Speaking of the geographical landscape, the market is bifurcated into regions namely Europe, South America, Asia Pacific, North America, and Middle East & Africa.
The worldwide wound irrigation solutions market was worth USD 1580.14 million in the year 2018 and is anticipated to expand with a CAGR of 3.5% through the year 2027, thereby reaching USD 2153.51 million.
The prominent companies operating in wound irrigation solutions market include B. Braun Melsungen AG, C.R. Bard, Inc., Convatec Group Plc., Smith & Nephew, Schulke & Mayr, Medline Industries, Inc., Novabay Pharmaceuticals, Inc., Reckitt Benckiser Group Plc., Cardinal Health, Inc., and Coloplast Group.